Skip to main content
Top
Published in: Clinical Rheumatology 5/2018

01-05-2018 | Review Article

On chronic fatigue syndrome and nosological categories

Authors: Kassem Sharif, Abdulla Watad, Nicola Luigi Bragazzi, Michael Lichtbroun, Mariano Martini, Carlo Perricone, Howard Amital, Yehuda Shoenfeld

Published in: Clinical Rheumatology | Issue 5/2018

Login to get access

Abstract

Chronic fatigue syndrome (CFS) is a heterogeneous disease which presents with pronounced disabling fatigue, sleep disturbances, and cognitive impairment that negatively affects patients’ functional capability. CFS remains a poorly defined entity and its etiology is still in question. CFS is neither a novel diagnosis nor a new medical condition. From as early as the eighteenth century, a constellation of perplexing symptoms was observed that resembled symptoms of CFS. Commencing with “febricula” and ending with CFS, many names for the disease were proposed including neurocirculatory asthenia, atypical poliomyelitis, Royal Free disease, effort syndrome, Akureyri disease, Tapanui disease, chronic Epstein-Barr virus syndrome, and myalgic encephalitis. To date, it remains unclear whether CFS has an autoimmune component or is a condition that precedes a full-blown autoimmune disease. Research suggests that CFS may overlap with other diseases including postural orthostatic tachycardia syndrome (POTS), autoimmune syndrome induced by adjuvants (ASIA), and Sjögren’s syndrome. Additionally, it has been postulated that the earliest manifestations of some autoimmune diseases can present with vague non-specific symptoms similar to CFS. Sometimes only when exposed to a secondary stimulus (e.g., antigen) which could accelerate the natural course of the disease would an individual develop the classic autoimmune disease. Due to the similarity of symptoms, it has been postulated that CFS could simply be an early manifestation of an autoimmune disease. This paper will provide a historical background review of this disease and a discussion of CFS as an entity overlapping with multiple other conditions.
Literature
1.
go back to reference Reyes M, Gary HE Jr, Dobbins JG, Randall B, Steele L, Fukuda K, Holmes GP, Connell DG, Mawle AC, Schmid DS, Stewart JA, Schonberger LB, Gunn WJ, Reeves WC (1997) Surveillance for chronic fatigue syndrome—four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ: Morb Mortal Wkly Rep CDC Surveill Summ 46(2):1–13 Reyes M, Gary HE Jr, Dobbins JG, Randall B, Steele L, Fukuda K, Holmes GP, Connell DG, Mawle AC, Schmid DS, Stewart JA, Schonberger LB, Gunn WJ, Reeves WC (1997) Surveillance for chronic fatigue syndrome—four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ: Morb Mortal Wkly Rep CDC Surveill Summ 46(2):1–13
9.
10.
11.
go back to reference Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2004) IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo (Athens, Greece) 18(2):101–106 Lerner AM, Beqaj SH, Deeter RG, Fitzgerald JT (2004) IgM serum antibodies to Epstein-Barr virus are uniquely present in a subset of patients with the chronic fatigue syndrome. In Vivo (Athens, Greece) 18(2):101–106
13.
go back to reference Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T (1998) Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1(1):143–146PubMed Kuratsune H, Yamaguti K, Sawada M, Kodate S, Machii T, Kanakura Y, Kitani T (1998) Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med 1(1):143–146PubMed
14.
go back to reference Byrne E (1991) The chronic fatigue syndrome: a reappraisal and unifying hypothesis. Clin Exp Neurol 28:128–138PubMed Byrne E (1991) The chronic fatigue syndrome: a reappraisal and unifying hypothesis. Clin Exp Neurol 28:128–138PubMed
15.
go back to reference Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990) Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28(6):1403–1410PubMedPubMedCentral Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990) Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 28(6):1403–1410PubMedPubMedCentral
17.
go back to reference Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP, Lane RJ (1991) A report—chronic fatigue syndrome: guidelines for research. J R Soc Med 84(2):118–121CrossRefPubMedPubMedCentral Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, Edwards RH, Hawton KE, Lambert HP, Lane RJ (1991) A report—chronic fatigue syndrome: guidelines for research. J R Soc Med 84(2):118–121CrossRefPubMedPubMedCentral
19.
go back to reference Manningham R (1760) The symptoms, nature, causes, and cure of the febricula, or, little fever: commonly called the nervous or hysteric fever; the fever on the spirits; vapours, hypo, or spleen. By Sir Richard Manningham, Knt. M. D. F. R. S. and of the College of Physicians, London. The fourth edition. edn. printed for G. Kearsly, at the Golden-Lion in Ludgate-Street, London Manningham R (1760) The symptoms, nature, causes, and cure of the febricula, or, little fever: commonly called the nervous or hysteric fever; the fever on the spirits; vapours, hypo, or spleen. By Sir Richard Manningham, Knt. M. D. F. R. S. and of the College of Physicians, London. The fourth edition. edn. printed for G. Kearsly, at the Golden-Lion in Ludgate-Street, London
21.
go back to reference Oppenheimer BS (1942) Neurocirculatory asthenia and related problems in military medicine. Bull N Y Acad Med 18(6):367–382PubMedPubMedCentral Oppenheimer BS (1942) Neurocirculatory asthenia and related problems in military medicine. Bull N Y Acad Med 18(6):367–382PubMedPubMedCentral
24.
go back to reference Shoenfeld Y, Shapiro Y, Drory Y, Glasevsky V, Sohar E, Kellerman JJ (1978) Rehabilitation of patients with NCA (neurocirculatory asthenia) through a short term training program. Am J Phys Med 57(1):1–8PubMed Shoenfeld Y, Shapiro Y, Drory Y, Glasevsky V, Sohar E, Kellerman JJ (1978) Rehabilitation of patients with NCA (neurocirculatory asthenia) through a short term training program. Am J Phys Med 57(1):1–8PubMed
25.
go back to reference Patarca-Montero R (2004) Medical etiology, assessment, and treatment of chronic fatigue and malaise. Haworth Press 6–7 Patarca-Montero R (2004) Medical etiology, assessment, and treatment of chronic fatigue and malaise. Haworth Press 6–7
26.
go back to reference Shorter E (1993) Chronic fatigue in historical perspective. CIBA Found Symp 173:6–16 discussion 16-22PubMed Shorter E (1993) Chronic fatigue in historical perspective. CIBA Found Symp 173:6–16 discussion 16-22PubMed
30.
go back to reference Ali N (2015) Understanding chronic fatigue syndrome. Rowman & Littlefield Ali N (2015) Understanding chronic fatigue syndrome. Rowman & Littlefield
32.
go back to reference Poore M, Snow P, Paul C (1984) An unexplained illness in West Otago. N Z Med J 97(757):351–354PubMed Poore M, Snow P, Paul C (1984) An unexplained illness in West Otago. N Z Med J 97(757):351–354PubMed
39.
go back to reference David AS, Wessely S, Pelosi AJ (1988) Postviral fatigue syndrome: time for a new approach. Br Med J (Clin Res Ed) 296(6623):696–699CrossRef David AS, Wessely S, Pelosi AJ (1988) Postviral fatigue syndrome: time for a new approach. Br Med J (Clin Res Ed) 296(6623):696–699CrossRef
43.
go back to reference Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D, Blate M, Klimas NG, Balbin EG, Bateman L, Allen A, Lapp CW, Springs W, Kogelnik AM, Phan CC, Danver J, Podell RN, Fitzpatrick T, Peterson DL, Gottschalk CG, Rajeevan MS (2017) Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol 185(8):617–626. https://doi.org/10.1093/aje/kwx029 CrossRefPubMedPubMedCentral Unger ER, Lin JS, Tian H, Natelson BH, Lange G, Vu D, Blate M, Klimas NG, Balbin EG, Bateman L, Allen A, Lapp CW, Springs W, Kogelnik AM, Phan CC, Danver J, Podell RN, Fitzpatrick T, Peterson DL, Gottschalk CG, Rajeevan MS (2017) Multi-site clinical assessment of myalgic encephalomyelitis/chronic fatigue syndrome (MCAM): design and implementation of a prospective/retrospective rolling cohort study. Am J Epidemiol 185(8):617–626. https://​doi.​org/​10.​1093/​aje/​kwx029 CrossRefPubMedPubMedCentral
47.
53.
go back to reference Okamoto LE, Raj SR, Peltier A, Gamboa A, Shibao C, Diedrich A, Black BK, Robertson D, Biaggioni I (2012) Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes. Clin Sci (Lond, Engl: 1979) 122(4):183–192. https://doi.org/10.1042/cs20110200 CrossRef Okamoto LE, Raj SR, Peltier A, Gamboa A, Shibao C, Diedrich A, Black BK, Robertson D, Biaggioni I (2012) Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes. Clin Sci (Lond, Engl: 1979) 122(4):183–192. https://​doi.​org/​10.​1042/​cs20110200 CrossRef
55.
go back to reference Agmon-Levin N, Zafrir Y, Kivity S, Balofsky A, Amital H, Shoenfeld Y (2014) Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA). Immunol Res 60(2–3):376–383. https://doi.org/10.1007/s12026-014-8604-2 CrossRefPubMed Agmon-Levin N, Zafrir Y, Kivity S, Balofsky A, Amital H, Shoenfeld Y (2014) Chronic fatigue syndrome and fibromyalgia following immunization with the hepatitis B vaccine: another angle of the ‘autoimmune (auto-inflammatory) syndrome induced by adjuvants’ (ASIA). Immunol Res 60(2–3):376–383. https://​doi.​org/​10.​1007/​s12026-014-8604-2 CrossRefPubMed
56.
go back to reference Tsai CK CH, Cheng CA (2011) Novel H1N1 influenza vaccine the cause of postural orthostatic tachycardia syndrome followed by cerebral hypoperfusion. J Med Sci 31:91–93 Tsai CK CH, Cheng CA (2011) Novel H1N1 influenza vaccine the cause of postural orthostatic tachycardia syndrome followed by cerebral hypoperfusion. J Med Sci 31:91–93
61.
62.
go back to reference Scanzi F, Andreoli L, Martinelli M, Taraborelli M, Cavazzana I, Carabellese N, Ottaviani R, Allegri F, Franceschini F, Agmon-Levin N, Shoenfeld Y, Tincani A (2017) Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures. Immunol Res 65(1):150–156. https://doi.org/10.1007/s12026-017-8912-4 CrossRefPubMed Scanzi F, Andreoli L, Martinelli M, Taraborelli M, Cavazzana I, Carabellese N, Ottaviani R, Allegri F, Franceschini F, Agmon-Levin N, Shoenfeld Y, Tincani A (2017) Are the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) and the undifferentiated connective tissue disease (UCTD) related to each other? A case-control study of environmental exposures. Immunol Res 65(1):150–156. https://​doi.​org/​10.​1007/​s12026-017-8912-4 CrossRefPubMed
Metadata
Title
On chronic fatigue syndrome and nosological categories
Authors
Kassem Sharif
Abdulla Watad
Nicola Luigi Bragazzi
Michael Lichtbroun
Mariano Martini
Carlo Perricone
Howard Amital
Yehuda Shoenfeld
Publication date
01-05-2018
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 5/2018
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4009-2

Other articles of this Issue 5/2018

Clinical Rheumatology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine